0.8435
-0.0186
(-2.15%)
As of 11:09:26 AM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ARKOWITZ DAVID A. Chief Financial Officer | Sale | Feb 16, 2024 | 182,442 |
| CLOGHESSY PAULA Officer | Sale | Oct 30, 2023 | 45,684 |
| DESROSIER THOMAS J Officer | Sale | Nov 18, 2024 | 135,192 |
| EGE DAVID S. Chief Technology Officer | Sale | Aug 16, 2024 | 77,575 |
| HENN MATTHEW R Officer | Sale | Nov 18, 2024 | 77,770 |
| SHAFF ERIC D Chief Executive Officer | Sale | Nov 18, 2024 | 170,389 |
| VON MOLTKE LISA Officer | Sale | Nov 18, 2024 | 32,415 |
| YOUNG TERESA L. Officer | Sale | Nov 18, 2024 | 90,404 |
Related Tickers
LXRX Lexicon Pharmaceuticals, Inc.
0.9805
-0.96%
SGMO Sangamo Therapeutics, Inc.
1.1500
-0.86%
MRSN Mersana Therapeutics, Inc.
0.6099
-5.19%
PDSB PDS Biotechnology Corporation
1.4800
-4.52%
ALLK Allakos Inc.
0.2611
-78.42%
XFOR X4 Pharmaceuticals, Inc.
0.4732
-0.90%
ERNA Eterna Therapeutics Inc.
0.5145
-9.11%
CDIO Cardio Diagnostics Holdings, Inc.
0.4849
+5.55%
QNRX Quoin Pharmaceuticals, Ltd.
0.3600
-5.49%
XLO Xilio Therapeutics, Inc.
0.7549
-7.95%